SCHEMBL1103633

SCHEMBL1103633

c1ccc(-c2c3ccccc3c(-c3ccc4c(-c5ccccc5)c5cnccc5c(-c5ccccc5)c4c3)c3ccccc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 1/20 0.42
TNF P01375 1/20 0.41
ALOX5 P09917 1/20 0.40
CSNK2A2 P19784 1/20 0.40
CSNK2B P67870 1/20 0.40
MAP2 P11137 1/20 0.39
KDM4E B2RXH2 2/20 0.38
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
NOTUM Q6P988 1/20 0.38
POLB P06746 1/20 0.38
HTT P42858 1/20 0.38
RAD52 P43351 1/20 0.38
MKNK1 Q9BUB5 1/20 0.37
ACHE P22303 1/20 0.37
GABRP O00591 1/20 0.37
GABRD O14764 1/20 0.37
IKBKB O14920 1/20 0.37
AURKA O14965 1/20 0.37
CHUK O15111 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1103619 0.93 MAPK10 (0.45) MAPK10TNFALOX5CSNK2A2CSNK2B
SCHEMBL1103647 0.91 CYP11B1 (0.50) MAPK10TNFALOX5ESR1ESR2
SCHEMBL1102900 0.91 TNF (0.47) MAPK10TNFALOX5MAP2KDM4E
SCHEMBL1102806 0.91 TNF (0.47) MAPK10TNFALOX5MAP2KDM4E
SCHEMBL1102798 0.91 TNF (0.47) MAPK10TNFALOX5MAP2KDM4E
SCHEMBL1102677 0.91 TNF (0.47) MAPK10TNFALOX5MAP2KDM4E
SCHEMBL1102558 0.89 KDM4E (0.43) MAPK10TNFCSNK2A2CSNK2BKDM4E
SCHEMBL1102701 0.89 TNF (0.47) MAPK10TNFALOX5CSNK2A2CSNK2B
SCHEMBL1102927 0.89 TNF (0.47) MAPK10TNFALOX5CSNK2A2CSNK2B
SCHEMBL1102483 0.89 NOTUM (0.48) MAPK10TNFALOX5MAP2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 MAPK10 1869/4885TNF 3803/4885ALOX5 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.